Study title: The effect of amblyopia therapy on ocular alignment. Repka MX, Holmes JM, Melia BM, Beck RW, Gearinger MD, Tamkins SM, Wheeler DT; Pediatric Eye Disease Investigator Group. J AAPOS. 2005 Dec;9(6):542-5.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Eye Diseases [C11] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: ATROPINE | |||||
ATC code: | |||||
Document link: The effect of amblyopia therapy on ocular alignment.pdf | |||||
Document date: 2011-09-13 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |